| Masters Courses | ||||
| # | Course No. | Course Title | Course Credit | Syllabus |
| 1 | ABT 601 | BASIC & APPLIED BIOTECHNOLOGY | 3(3 + 0) | |
| 2 | ABT 602 * | FUNDAMENTALS OF CELL & MOLECULAR BIOLOGY | 3(3 + 0) | |
| 3 | ABT 603 | APPLIED MOLECULAR BIOLOGY | 3(2 + 1) | |
| 4 | ABT 604 * | ANIMAL CELL CULTURE: PRINCIPLES AND APPLICATIONS | 3(1 + 2) | |
| 5 | ABT 605 * | MOLECULAR DIAGNOSTICS | 3(1 + 2) | |
| 6 | ABT 606 | VACCINE BIOTECHNOLOGY | 3(2 + 1) | |
| 7 | ABT 607 | IMMUNOLOGY APPLIED TO BIOTECHNOLOGY | 2(1 + 1) | |
| 8 | ABT 608 | INTRODUCTION TO BIOINFORMATICS | 3(2 + 1) | |
| 9 | ABT 609 * | ANIMAL GENOMICS | 3(2 + 1) | |
| 10 | ABT 610 * | REPRODUCTIVE BIOTECHNOLOGY | 3(2 + 1) | |
| 11 | ABT 611 * | TECHNIQUES IN MOLECULAR BIOLOGY AND GENETIC ENGINEERING | 3(0 + 3) | |
| 12 | ABT 612 | BIODIVERSITY, BIOSAFETY AND BIOETHICS | 2(2 + 0) | |
| 13 | ABT 613 | MOLECULAR FORENSICS | 3(2 + 1) | |
| 14 | ABT 614 | INDUSTRIAL BIOTECHNOLOGY | 3(2 + 1) | |
| 15 | ABT 615 | PROBIOTICS AND FEED BIOTECHNOLOGY | 3(3 + 0) | |
| 16 | ABT 616 | ANIMAL BIOTECHNOLOGY | 3(3 + 0) | |
| 17 | ABT691 | MASTER'S SEMINAR | 1(1 + 0) | * courses are compulsory |
| PhD Courses | ||||
| # | Course No. | Course Title | Course Credit | Syllabus |
| 1 | ABT 701 | GENE CLONING AND EXPRESSION | 2(1 + 1) | |
| 2 | ABT 702 | FUNCTIONAL GENOMICS AND PROTEOMICS | 3(2 + 1) | |
| 3 | ABT 703 | ADVANCES IN REPRODUCTIVE BIOTECHNOLOGY | 3(2 + 1) | |
| 4 | ABT 704 | TRENDS IN VACCINOLOGY | 3(3 + 0) | |
| 5 | ABT 705 | ADVANCES IN ANIMAL CELL CULTURE | 3(2 + 1) | |
| 6 | ABT 706 | TRANSGENIC ANIMAL TECHNOLOGY | 2(2 + 0) | |
| 7 | ABT 791 | DOCTORAL SEMINAR I | 1(1 + 0) | |
| 8 | ABT 792 | DOCTORAL SEMINAR II | 1(1 + 0) | * courses are compulsory |
In academics:
1. Obtained DBT support for MVSc program in Animal Biotechnology since inception in 2010-11 and continued for the 15th Finance Commission period till 2024-25.
2. Till date 37 MVSc and 4 PhD students successfully completed degree in Animal Biotechnology.
3. Three students of the department received prestigious fellowship for higher studies abroad in countries like Netherlands, Belgium and Canada.
a) Dr. Soumya Kanti Kar, who passed M.V.Sc. in Animal Biotechnology from this department in the first batch (2010-2012) was selected for pursuing Ph.D. at Wageningen University, the Netherlands in the year 2012. After completion of his Ph.D., he has been appointed as a Scientist at the Institute of Livestock Research at the same university.
b) Dr. Luit Moni Barkalita, Assistant Professor, , Department of Animal Biotechnology, was awarded Netaji-Subhas International Fellowship, 2017-18 by ICAR, New Delhi to pursue Ph.D. at Rega Institute of Medical Research, KU Leuven, Leuven, Belgium-3000. He left for Belgium on 23rd September, 2018 on study leave to pursue his higher studies.
c) Dr. Ankita Saikia, an MVSc student, Department of Animal Biotechnology, has been awarded Tri-Council Research Funding (International fellowship) to pursue MS Course in Animal science in the department of Animal Sciences, University of Manitoba, Canada.
4. More than 75% pass out students of the Department cleared NET so far.
5. More than 70% students got placement in public and private sectors including one in abroad and two in administrative service.
6. Two post-doc students of General Biotechnology receiving DBT-RA fellowship completed their research in the department under the mentorship of Dr. P. Borah, HoD.
7. Organized 45 hands-on training programmes on various aspects of molecular biology, biotechnology and bioinformatics during the last 10 years.
In research:
1. Completed 5 (five) externally funded research projects and 4 (four) others are ongoing.
2. Published more than 20 research papers in reputed international peer-reviewed journals with NAAS factor 7.5 or more during the last 5 years alone, besides more than 30 other papers published in journals of national repute.
3. Provided mentorship and facilities to 86 external students since inception for doing research in the department.
4. The department has been recognized and sponsored as the Advance Level State Biotech Hub by DBT, Govt. of India for last 11 years.
5. Vaccine candidate Identified and evaluated:
a) Development of nanoparticles as vaccine adjuvants:
· Standardized a procedure of development of a Chitosan nanoparticle (ChNP) adjuvanted Salmonella Typhimurium outer membrane vesicle (OMV) complex vaccine. The ChNP-OMV (S. Typhimurium) vaccine was found to be capable of inducing prompt and strong immune response in mice and chicken.
· Standardized the procedure of preparation of an aluminium hydroxide nanoparticle adjuvanted bivalent Pasteurella multocida outer-membrane protein (capsular types A and D) complex vaccine. Evaluation of the immunopotential of the bivalent vaccine in mice revealed that it was highly efficient in stimulating IgG response against P. multocida capsular type A.
b) Expression of T2544 gene of Salmonella enteritidis in E. coli host and evaluation of immunogenicity of the recombinant protein in mice. The recombinant protein was found to induce strong immunity in mice.
c) A DNA vaccine expressing the ompH gene of Pasteurella multocida was developed against swine pasteurellosis which showed promising immunogenicity in laboratory animal models.
6. Microbial typing:
a) Virulence gene profiling and molecular typing of Staphylococcus aureus isolated from bovine mastitis.
b) Isolation, toxin profiling and molecular characterization of Clostridium difficile isolates from raw meat, meat products and fish products.
7. Isolation of bifidobacteria with probiotic potential from animal sources.
8. Formulation of a suitable medium for verification of goat follicular oocytes.
9. Production of cloned goat embryos by hand-made cloning.
10. Patent applied (Docket No. 40921 dtd. 17.12.2015) on “Whole outer membrane protein of Salmonella Typhimurium adjuvanted with calcium phosphate nanoparticles as vaccine against salmonellosis in chicken”.
11. Technologies developed/transferred/commercialized, if any:
The following technologies have been developed in the department since inception. However, they are not yet commercialized.
a) A recombinant PagN subunit vaccine against salmonellosis.
b) A DNA vaccine expressing the ompH gene of Pasteurella multocida against swine pasteurellosis
c) Standardized a procedure of production of a Chitosan nanoparticle (ChNP) adjuvanted Salmonella Typhimurium outer membrane vesicle (OMV) complex vaccine.
d) Standardized the procedure of preparation of an aluminium hydroxide nanoparticle adjuvanted bivalent Pasteurella multocida outer-membrane protein (capsular types A and D) complex vaccine.
e) Developed a Multiplex-PCR assay for simultaneous detection of major virulence genes of Salmonella enterica isolates from diverse sources.
f) Prediction of 3D structure of the antigenic components of the PagN protein of Salmonella using Bioinformatics facility and in vitro validation of the immunogenicity of the protein.
g) Development of a manual Rep-PCR based method for rapid molecular typing of Salmonella which is comparable to PFGE, the gold standard method in terms of its efficacy.
h) Development of a multiplex PCR based genotyping method for rapid identification of clinically important serovars of Salmonella enterica supported by an online database server.
In extension:
· The teachers and students participated in a number of extension camps organized from time time by Directorate of Extension Education and a number of lectures have also been delivered by the HOD.
· The HoD also delivered more than 170 online and offline lectures during the last 11 years in training/ webinars / seminars organized by different institutions on various topics.
1.jpg)
